Added to YB: 2024-02-29
Pitch date: 2024-02-29
ICAD [bullish]
iCAD, Inc.
+112.64%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.
Market Cap
$47.6M
Pitch Price
$1.82
Price Target
6.00 (+55%)
Dividend
N/A
EV/EBITDA
-5.90
P/E
-8.21
EV/Sales
1.57
Sector
Health Care Technology
Category
growth
$ICAD - Paves the Way for Growth in AI Medtech Sector
$ICAD: AI medtech transitioning to SaaS, capturing big early TAM in cancer detection. Was <1x EV/Sales w/ 50% ARR. $24M cash, no debt, near breakeven. Peer $VHT.AX bought at ~8x sales, implies $6 for ICAD pre-growth. Microcaps can reward research. Long.
Read full article (1 min)